Clinical Guest Contributors

  1. Rethinking Clinical Development In The Age Of Synthetic Cell Therapy 9/5/2025

    Synthetic biology, especially when applied to engineered stem cells, such as induced mesenchymal stem cells (iMSCs), represents a new frontier. But to get these cells to patients, we need to reimagine how we develop and evaluate them.

  2. How Digital Twins Are Rewriting Clinical Trials 9/2/2025

    While the benefits of digital twins to accelerate clinical trials are undeniable, many questions about their use are still unanswered and go far beyond technology.

  3. 3 Quick Takes From A PI With 100+ Trials To His Name 8/29/2025

    Principal investigator Norman B. Gaylis, MD, shares his perspective on patient recruitment, protocol design, and vendor selection.

  4. Alzheimer's Trial Targeting Amyloid Beta Oligomers Sees Cost Savings, Patient Satisfaction With New Screening 8/29/2025

    Acumen Pharmaceuticals' Eric Siemers, MD, discusses their novel Alzheimer's disease screening method and trial design for investigational drug sabirnetug that keeps both the clinical site and patient experience in mind. 

  5. Insuring Global Clinical Trials: Navigating Risks Across Borders 8/28/2025

    Foreign clinical trials insurance is indispensable. Learn its features, its benefits, and why it's needed.

  6. Misconceptions About Cancer Clinical Trials And How To Overcome Them 8/27/2025

    Medical oncologist Wasif Saif, MD, MBBS, discusses many of the misconceptions held by patients and clinicians about cancer clinical trials.

  7. RWE Is Not Optional, It's Essential 8/25/2025

    UCB Head of Medical Strategy, Bone Health, Jennifer Timoshanko explains why RWE is a valuable alternative to RCTs and shares best practices for collecting it.

  8. Where The FDA And EMA Stand On Digital Endpoints 8/22/2025

    In part two of this series on digital endpoints, consultant Anita Burrell reviews the extent of their regulatory acceptance and discusses how to ensure data produced from digital technologies satisfies regulators.

  9. How AI Can Accelerate Clinical Trials' Probabilities Of Technical And Regulatory Success (PTRS) 8/21/2025

    AI expert Kelly H. Zou, Ph.D., explores how the technology can drive R&D successes, including clinical trials.

  10. What Clinical Operations Should Know About Medical Affairs And MSLs 8/20/2025

    Having spent years in medical affairs and leading MSL teams, William Soliman, Ph.D., BCMAS, explores how clinical operations and medical affairs thrive in collaboration or struggle in silos and offers tips for better partnerships.